Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| W.W. GRAINGER, INC.GWW · Entity 2997 | Director · Chairman of the Board | April 03, 2017 | April 04, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
W.W. GRAINGER, INC.
Report date April 03, 2017 · Filed April 04, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $231.20 · Expires 2027-04-02 | Direct | 108,581 |
Reported balance
After 2017-04-03 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2017-04-03 · Grant · Acquired 108,581 · Balance 108,581 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $108.15 · Expires 2020-04-27 | Direct | 122,000 |
Reported balance
Holding disclosure · report date 2017-04-03 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 122,000 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $149.02 · Expires 2021-04-26 | Direct | 96,400 |
Reported balance
Holding disclosure · report date 2017-04-03 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 96,400 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $204.01 · Expires 2022-04-24 | Direct | 78,100 |
Reported balance
Holding disclosure · report date 2017-04-03 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 78,100 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $245.86 · Expires 2023-04-23 | Direct | 70,465 |
Reported balance
Holding disclosure · report date 2017-04-03 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 70,465 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $248.22 · Expires 2024-04-29 | Direct | 56,558 |
Reported balance
Holding disclosure · report date 2017-04-03 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 56,558 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $231.88 · Expires 2025-03-31 | Direct | 65,816 |
Reported balance
Holding disclosure · report date 2017-04-03 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 65,816 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $234.38 · Expires 2026-03-31 | Direct | 78,152 |
Reported balance
Holding disclosure · report date 2017-04-03 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 78,152 |
| Common StockSEC Table I · non-derivative | Direct | 163,478 |
Reported balance
Holding disclosure · report date 2017-04-03 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 163,478 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 03, 2017 Filed Apr 4, 2017 19:53 UTC | W.W. GRAINGER, INC. GWW · Entity 2997 | GrantStock Option · Derivative | 108,581 | $0.00 Strike: $231.20 | $0.00 |
DisclosureSEC source: 0001209191-17-024644 · doc4.xml · derivative · entry 9 RYAN JAMES T · CIK 0001187064 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,581 Underlying: Common Stock · 108,581 shares Expires 2027-04-02 Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 17:23 UTC | W.W. GRAINGER, INC. GWW · Entity 2997 | SaleCommon Stock | 2,369 | $252.46 | $598,086.03 |
DisclosureSEC source: 0001209191-17-011905 · doc4.xml · nonDerivative · entry 3 RYAN JAMES T · CIK 0001187064 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,478 F1 · kind: Transaction pursuant to a previously adopted Rule 10b5-1 trading program. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 17:23 UTC | W.W. GRAINGER, INC. GWW · Entity 2997 | Tax withholdingCommon Stock | 1,995 | $232.25 | $463,338.75 |
DisclosureSEC source: 0001209191-17-011905 · doc4.xml · nonDerivative · entry 2 RYAN JAMES T · CIK 0001187064 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,847 Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 17:23 UTC | W.W. GRAINGER, INC. GWW · Entity 2997 | GrantCommon Stock | 4,364 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-011905 · doc4.xml · nonDerivative · entry 1 RYAN JAMES T · CIK 0001187064 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,842 Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 19:12 UTC | W.W. GRAINGER, INC. GWW · Entity 2997 | Exercise / conversionStock Option · Derivative | 65,000 | $0.00 Strike: $81.49 | $0.00 |
DisclosureSEC source: 0001209191-17-000697 · doc4.xml · derivative · entry 4 RYAN JAMES T · CIK 0001187064 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 65,000 shares Expires 2019-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction pursuant to a previously adopted Rule 10b5-1 trading program. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 19:12 UTC | W.W. GRAINGER, INC. GWW · Entity 2997 | SaleCommon Stock | 65,000 | $234.17 | $15,221,095.50 |
DisclosureSEC source: 0001209191-17-000697 · doc4.xml · nonDerivative · entry 3 RYAN JAMES T · CIK 0001187064 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,478 F1 · kind: Transaction pursuant to a previously adopted Rule 10b5-1 trading program. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 19:12 UTC | W.W. GRAINGER, INC. GWW · Entity 2997 | Exercise / conversionCommon Stock | 65,000 | $81.49 | $5,296,850.00 |
DisclosureSEC source: 0001209191-17-000697 · doc4.xml · nonDerivative · entry 2 RYAN JAMES T · CIK 0001187064 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 228,478 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction pursuant to a previously adopted Rule 10b5-1 trading program. Read SEC document |
| December 16, 2016 Filed Jan 4, 2017 19:12 UTC | W.W. GRAINGER, INC. GWW · Entity 2997 | GiftCommon Stock | 4,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-000697 · doc4.xml · nonDerivative · entry 1 RYAN JAMES T · CIK 0001187064 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,478 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.